-
Full funding announced for continuous Type 1 diabetes management systems
The Yukon government will now fund continuous glucose monitoring systems for Type 1 diabetics after local advocates began asking for donations from businesses to make up for a lack of government coverage. “We recognize the challenges Yukoners and families who live with Type 1 diabetes face on a daily basis…
-
Has the Pandemic Changed Type 1 Diabetes Care for Good?
MONDAY, Oct. 5, 2020 (HealthDay News) — When the COVID-19 pandemic began, many doctors started providing care via telemedicine. Now, a new survey of people with type 1 diabetes suggests many like remote care and hope it continues in the future. Among the survey respondents who had a telemedicine visit…
-
Dexcom Signs Multi-Year Collaboration Agreement with the University of Virginia…
SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM) today announced it has signed a five-year collaboration agreement with the University of Virginia to advance its research and development efforts on continuous glucose monitoring-based solutions. The research partnership will center on advancing Dexcom’s automated insulin delivery technology and exploring the use of continuous glucose…
-
Britons With Type 1 Diabetes Die Nearly 8 Years Earlier
Britons With Type 1 Diabetes Die Nearly 8 Years Earlier — But keeping HbA1c in check can mitigate this early mortality by Kristen Monaco, Staff Writer, MedPage Today September 23, 2020 The average British adult with type 1 diabetes loses about eight life-years compared with nondiabetic age peers, according to…
-
Bioprinted therapeutic offers novel solution for treating Type 1 Diabetes
VANCOUVER, BC, Sept. 22, 2020 /CNW/ – Type 1 Diabetes (T1D), once known as insulin dependent diabetes, is a chronic condition that causes pancreatic cells to produce little or no insulin. Insulin plays an important role in regulating blood sugar, or glucose, so T1D patients cannot naturally regulate their blood…
-
Penn study proves promising for type 1 diabetes cure
After a promising study by Penn researchers, a cure for type 1 diabetes appears to be closer to reality. A research team led by Penn scientists successfully transplanted insulin-producing cells into multiple animal models, PhillyVoice reported. In type 1 diabetes, beta cells in clusters called islets cannot regulate blood sugar…
-
Rethinking Type 1 diabetes with a radically new immunotherapy approach
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment Severe and chronic autoimmune diseases are some of the most difficult and complex immune system-related diseases to treat. Normally, the immune system…
-
Pro-inflammatory lipids precede Type 1 diabetes onset in mouse model and children
Type 1 diabetes, or T1D, is an autoimmune disease in which the body’s immune cells — led by inflammatory macrophages — attack and destroy the beta cells of the pancreas that produce insulin. Researchers have long tried to unravel the signaling that provokes this attack. One of the less-studied forms…
-
Major advancement in islet cell transplantation for treating Type-1 diabetes
A cure for Type-1 diabetes has come closer with the development of a new method for keeping transplanted insulin-producing cells alive and functional in recipients for long periods even when transplanted underneath the skin. A team led by researchers at the Perelman School of Medicine reports the new method, and…
-
Researchers Develop Potential Breakthrough in Type 1 Diabetes Treatment
Researchers from the Salk Institute took a major step forward in developing a new insulin-producing pancreatic cell cluster as a potential treatment for type 1 diabetes patients. The pancreatic cell clusters were developed with stem cell technology and were able to avoid detection by the immune system. That means the…
